Tochigi, Japan

Masaaki Yoshimura

This inventor holds 1 USPTO granted patent. Top assignee: Kao Corporation. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaaki Yoshimura. Retrieved from https://idiyas.com/inventor/masaaki-yoshimura-euer4vdc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaaki Yoshimura: Innovator in Macrophage Chemotactic Peptides

Introduction: Masaaki Yoshimura is a prominent inventor based in Tochigi, Japan, known for his groundbreaking work in the field of biochemistry. He has significantly contributed to the understanding of macrophage chemotactic activities through the development of novel physiologically active peptides.

Latest Patents: Masaaki Yoshimura holds a noteworthy patent titled "Novel peptides possessing a macrophage chemotactic activity." This invention focuses on innovative peptides that exhibit specific amino acid sequences capable of attracting macrophages, which play a vital role in the immune response and inflammation processes.

Career Highlights: Masaaki has made substantial strides in his career while working at Kao Corporation, a renowned company known for its commitment to innovation in various sectors, including health and beauty. His patent highlights his expertise and dedication to advancing medical science and therapeutic developments.

Collaborations: Throughout his career, Masaaki Yoshimura has collaborated with distinguished colleagues, including Toshiaki Osawa and Naonobu Yoshizuka. Together, they have worked on projects that harness the potential of biochemistry to address complex health challenges.

Conclusion: Masaaki Yoshimura stands out as an influential inventor whose contributions to the field of macrophage research have the potential to impact future therapeutic strategies. His dedication to innovation and collaboration at Kao Corporation exemplifies the spirit of research and development in contemporary science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…